NCT05686902

Brief Summary

The aim of this study is to determine the effect of two different skin care solutions used in stoma care on peristomal skin integrity and compare them with each other.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 17, 2023

Completed
12 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2024

Completed
Last Updated

October 23, 2024

Status Verified

October 1, 2024

Enrollment Period

6 months

First QC Date

December 30, 2022

Last Update Submit

October 21, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • skin pH measurement around stoma

    skin pH measurement around stoma will be measured with a portable device brand BRD

    change between the 0th and the 7th day

  • Skin temperature measurement around stoma

    Skin temperature measurement around stoma will be measured with a portable infrared device.

    change between the 0th and the 7th day

  • skin moisture around the soma

    percent of (%)skin moisture around the soma will be measured with a portable device brand BRD

    change between the 0th and the 7th day

  • Pittman Ostomy Complication Severity Index

    It is a 9-parameter evaluation scale developed by Joyce Pittman in 2014, and its validity and reliability in Turkish were performed by Arslantaş et al. in 2019. The purpose of the scale is to evaluate the frequency and severity of early postoperative complications during follow-up in individuals with stoma. This index Evaluates leakage, peristomal irritant dermatitis, pain, bleeding in or around the stoma, stomal necrosis, stenosis, retraction, mucocutaneous separation, and hyperplasia All complications 0 to 3 (0 = absent, 1 = mild, 2 = moderate, 3 = severe) (The total score ranges from 0 to 27. Higher scores indicate more severe ostomy complications)

    change between the 0th and the 7th day

Study Arms (2)

PH 5.5 BABY SHAMPOO GROUP

EXPERIMENTAL

Distilled water+Ph 5.5 baby shampoo for stoma care of patients in the first group

Other: CLEANING SOLUTION

SERUM PHYSIOLOGIC GROUP

ACTIVE COMPARATOR

0.9% saline solution for stoma care of patients in the second group

Other: CLEANING SOLUTION

Interventions

The difference in peristomal skin integrity between the groups will be examined.

PH 5.5 BABY SHAMPOO GROUPSERUM PHYSIOLOGIC GROUP

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients who volunteered to participate in the study and received Informed Voluntary Consent from their parents.
  • Products used in routine clinical care in skin care (distilled water + baby shampoo), patients for whom the use of 0.9% saline is appropriate
  • Patients who do not have any other underlying disease that may affect peristomal skin integrity
  • Patients included in the study from the 0th day following the colostomy opening
  • Patients who can be observed at least on the 7th day

You may not qualify if:

  • Patients who did not volunteer to participate in the study and who could not obtain Informed Voluntary Consent from their parents
  • Patients with a stoma other than a colostomy (ileostomy, etc.)
  • Products used in routine clinical care in skin care (distilled water + baby shampoo), patients for whom the use of 0.9% saline is not suitable
  • Patients with another underlying disease that may affect peristomal skin integrity
  • Patients on the 1st day and after the colostomy opening
  • Patients who cannot be observed for at least 7 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Behçet Uz Hospital

Izmir, Turkey (Türkiye)

Location

Study Officials

  • Esra ARDAHAN AKGÜL, Asst. Prof.

    İzmir Katip Çelebi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Principal Investigator

Study Record Dates

First Submitted

December 30, 2022

First Posted

January 17, 2023

Study Start

January 1, 2024

Primary Completion

July 1, 2024

Study Completion

October 20, 2024

Last Updated

October 23, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations